Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Evidence mounts against diabetes drug

Nature (2010)Cite this article

Subjects

Studies continue to find heart-attack risk.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Graham, D. J. et al. J. Am. Med. Assoc. advance online publication doi:10.1001/jama.2010.920 (2010).

  2. Nissen, S. E. & Wolski, K. N. Engl. J. Med. 356, 2457-2471 (2007).

    Article  Google Scholar 

  3. Nissen, S. E. & Wolski, K. Arch. Intern. Med. advance online publication doi:10.1001/archinternmed.2010.207 (2010).

Download references

Authors
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related external links

Avandia (rosiglitazone)

GSK clinical trial register

FDA advisory committees July 2010 joint meeting

Pharmalot

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ledford, H. Evidence mounts against diabetes drug. Nature (2010). https://doi.org/10.1038/news.2010.320

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2010.320

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing